INTEGRA LIFESCIENCES HOLDINGS CORP Operating Lease, Expense
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Operating Lease, Expense of $13.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for the quarter ending 2026-06-30 was $6.60M, a 10.00% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for the quarter ending 2026-03-31 was $6.40M, a 8.47% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for the quarter ending 2025-12-31 was $6.10M, a 10.91% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for the quarter ending 2025-09-30 was $5.90M, a 1.67% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for fiscal 2025 was $23.90M, a 1.65% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for fiscal 2024 was $24.30M, a 1.25% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for fiscal 2023 was $24.00M, a 6.19% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP operating lease, expense for fiscal 2022 was $22.60M, a 11.33% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $13.00M 10-Q · filed 2026-07-29 | $19.10M derived: sum of 3 quarters · filed 2026-07-29 | $25.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $6.40M 10-Q · filed 2026-05-05 | $12.50M derived: sum of 2 quarters · filed 2026-05-05 | $18.40M derived: sum of 3 quarters · filed 2026-05-05 | $24.40M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.00M derived: sum of 2 quarters · filed 2026-02-26 | $18.00M derived: sum of 3 quarters · filed 2026-07-29 | $23.90M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $11.90M derived: sum of 2 quarters · filed 2026-07-29 | $17.80M 10-Q · filed 2025-10-30 | $23.30M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $11.90M 10-Q · filed 2026-07-29 | $17.40M derived: sum of 3 quarters · filed 2026-07-29 | $23.40M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $5.90M 10-Q · filed 2026-05-05 | $11.40M derived: sum of 2 quarters · filed 2026-05-05 | $17.40M derived: sum of 3 quarters · filed 2026-05-05 | $23.90M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.50M derived: sum of 2 quarters · filed 2026-02-26 | $18.00M derived: sum of 3 quarters · filed 2026-02-26 | $24.30M 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $12.50M derived: sum of 2 quarters · filed 2025-10-30 | $18.80M 10-Q · filed 2025-10-30 | $24.90M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $12.80M 10-Q · filed 2025-07-31 | $18.90M derived: sum of 3 quarters · filed 2025-07-31 | $25.00M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $6.30M 10-Q · filed 2025-05-05 | $12.40M derived: sum of 2 quarters · filed 2025-05-05 | $18.50M derived: sum of 3 quarters · filed 2025-05-05 | $24.30M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $12.20M derived: sum of 2 quarters · filed 2025-02-25 | $18.00M derived: sum of 3 quarters · filed 2025-02-25 | $24.00M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $11.90M derived: sum of 2 quarters · filed 2024-11-04 | $17.90M 10-Q · filed 2024-11-04 | $23.90M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $11.80M 10-Q · filed 2024-07-29 | $17.80M derived: sum of 3 quarters · filed 2024-07-29 | $24.20M derived: sum of 4 quarters · filed 2024-07-29 |
| 2023-03-31 | $6.00M 10-Q · filed 2024-05-06 | $12.00M derived: sum of 2 quarters · filed 2024-05-06 | $18.40M derived: sum of 3 quarters · filed 2024-05-06 | $23.70M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $12.40M derived: sum of 2 quarters · filed 2024-02-28 | $17.70M derived: sum of 3 quarters · filed 2024-02-28 | $22.60M 10-K · filed 2024-02-28 |
| 2022-09-30 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $11.70M derived: sum of 2 quarters · filed 2023-10-25 | $16.60M 10-Q · filed 2023-10-25 | $21.20M derived: sum of 4 quarters · filed 2023-10-25 |
| 2022-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $10.20M 10-Q · filed 2023-07-27 | $14.80M derived: sum of 3 quarters · filed 2023-07-27 | $19.90M derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | $4.90M 10-Q · filed 2023-04-26 | $9.50M derived: sum of 2 quarters · filed 2023-04-26 | $14.60M derived: sum of 3 quarters · filed 2023-04-26 | $19.90M derived: sum of 4 quarters · filed 2023-04-26 |
| 2021-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $9.70M derived: sum of 2 quarters · filed 2023-02-22 | $15.00M derived: sum of 3 quarters · filed 2023-02-22 | $20.30M 10-K · filed 2023-02-22 |
| 2021-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $10.40M derived: sum of 2 quarters · filed 2022-10-26 | $15.70M 10-Q · filed 2022-10-26 | $20.80M derived: sum of 4 quarters · filed 2022-10-26 |
| 2021-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $10.60M 10-Q · filed 2022-07-27 | $15.70M derived: sum of 3 quarters · filed 2022-07-27 | $20.60M derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-03-31 | $5.30M 10-Q · filed 2022-04-27 | $10.40M derived: sum of 2 quarters · filed 2022-04-27 | $15.30M derived: sum of 3 quarters · filed 2022-04-27 | $20.20M derived: sum of 4 quarters · filed 2022-04-27 |
| 2020-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.00M derived: sum of 2 quarters · filed 2022-02-24 | $14.90M derived: sum of 3 quarters · filed 2022-02-24 | $19.70M 10-K · filed 2022-02-24 |
| 2020-09-30 | $4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $9.80M derived: sum of 2 quarters · filed 2021-11-02 | $14.60M 10-Q · filed 2021-11-02 | $20.00M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $9.70M 10-Q · filed 2021-07-29 | $15.10M derived: sum of 3 quarters · filed 2021-07-29 | $20.30M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $4.80M 10-Q · filed 2021-04-29 | $10.20M derived: sum of 2 quarters · filed 2021-04-29 | $15.40M derived: sum of 3 quarters · filed 2021-04-29 | $20.00M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $10.60M derived: sum of 2 quarters · filed 2021-02-23 | $15.20M derived: sum of 3 quarters · filed 2021-02-23 | $19.60M 10-K · filed 2021-02-23 |
| 2019-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $9.80M derived: sum of 2 quarters · filed 2020-10-29 | $14.20M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.00M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $4.40M 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $8.40M derived: sum of 2 quarters · filed 2019-10-25 | $11.80M 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $6.50M 10-Q · filed 2019-07-25 | ||
| 2018-03-31 | $3.40M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |